Schizophrenia is a significant psychopathology marked by a variety of symptoms, such as delusions, hallucinations, disorganized thinking, and emotional flatness. Symptoms of schizophrenia often manifest in late adolescence or early adulthood and might include the following: Positive symptoms include hallucinations, delusions, and disordered thinking, which entail the existence of non-reality-based aberrant experiences or beliefs. Negative symptoms consisting of the absence of typical emotional or behavioral responses: emotional flatness, lack of desire, and trouble enjoying pleasure. Among the pharmacological therapies for schizophrenia are antipsychotic medicines, which are intended to lessen the disorder's positive symptoms. These drugs target particular neurotransmitters and receptor types in the brain, such as dopamine and serotonin. Antipsychotic drugs may be divided into two categories: normal and atypical. Typical antipsychotics, such as haloperidol and chlorpromazine, block the dopamine D2 receptor and are successful in lowering positive symptoms, such as hallucinations and delusions, but they often cause extrapyramidal symptoms (EPS) such as tremors, stiffness, and restlessness. Atypical antipsychotics, such as clozapine, risperidone, and olanzapine, target additional receptors, including as serotonin receptors, and are similarly useful in lowering unpleasant symptoms. Schizophrenia is a complicated condition, and several variables likely contribute to its onset. Heritability, or the hereditary effect on the condition, is thought to be around 80%. Multiple genetic variants, including polymorphisms in genes involved in neurotransmission and brain development, have been linked to an increased chance of developing schizophrenia. The prefrontal cortex, hippocampus, and amygdala, areas of the brain involved in perception, attention, and emotion, are commonly structurally and functionally different in individuals with schizophrenia, according to study. These disparities imply that the neuronal connections connecting these brain areas may be dysfunctional. Using imaging methods such as Magnetic Resonance Imaging (MRI), researchers have discovered, for instance, that persons with schizophrenia tend to have reduced quantities of gray matter in the prefrontal cortex and hippocampus. In addition, functional MRI studies have shown that individuals with schizophrenia exhibit aberrant activity in the prefrontal cortex, which is believed to be important in decision-making, working memory, and attention. Overall, schizophrenia is a significant psychopathology marked by a variety of symptoms, including delusions, hallucinations, abnormal thinking, and emotional flatness. Primarily, it is treated using antipsychotic drugs that target certain neurotransmitters and receptor types. Schizophrenia is believed to be impacted by a mix of hereditary and environmental variables, and research has shown structural and functional changes in brain areas involved in perception, attention, and emotion in individuals with schizophrenia. 